Tempest Therapeutics (TPST) Short Interest Ratio & Short Volume → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free TPST Stock Alerts $3.47 -0.15 (-4.14%) (As of 05:45 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Tempest Therapeutics Short Interest DataCurrent Short Volume1,130,000 sharesPrevious Short Volume969,700 sharesChange Vs. Previous Month+16.53%Dollar Volume Sold Short$3.77 millionShort Interest Ratio / Days to Cover1.2Last Record DateApril 15, 2024Outstanding Shares22,220,000 sharesFloat Size16,760,000 sharesShort Percent of Float6.74%Today's Trading Volume297,665 sharesAverage Trading Volume883,003 sharesToday's Volume Vs. Average34% Short Selling Tempest Therapeutics ? Sign up to receive the latest short interest report for Tempest Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTPST Short Interest Over TimeTPST Days to Cover Over TimeTPST Percentage of Float Shorted Over Time Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Tempest Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,130,000 shares $3.77 million +16.5%6.7%1.2 $3.34 3/31/2024969,700 shares $3.79 million +26.5%6.1%0.9 $3.91 3/15/2024766,800 shares $2.79 million +7.0%4.2%1 $3.64 2/29/2024716,500 shares $2.66 million -17.7%4.5%0.8 $3.71 2/15/2024870,400 shares $3.46 million +14.5%5.4%0.8 $3.98 1/31/2024759,900 shares $2.88 million +37.1%5.6%0.4 $3.79 Get the Latest News and Ratings for TPST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tempest Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024554,300 shares $2.34 million +19.6%4.1%0.2 $4.23 12/31/2023463,400 shares $2.04 million -44.8%3.4%0 $4.40 12/15/2023838,900 shares $3.45 million +31.4%6.2%0.1 $4.11 11/30/2023638,600 shares $2.24 million -54.1%5.8%0.1 $3.52 11/15/20231,390,000 shares $4.59 million -0.7%12.5%0.1 $3.30 10/31/20231,400,000 shares $5.74 million -36.1%18.2%0.1 $4.10 10/15/20232,190,000 shares $7.97 million +7,200.0%28.5%0.3 $3.64 9/30/202330,000 shares $9,141.00 -64.7%0.4%0.1 $0.30 9/15/202385,000 shares $41,378.00 +161.5%1.1%0.6 $0.49 8/31/202332,500 shares $17,485.00 +128.9%0.5%0.3 $0.54 8/15/202314,200 shares $9,315.20 -58.6%0.2%0.1 $0.66 7/31/202334,300 shares $33,271.00 -15.9%0.6%0.4 $0.97 7/15/202340,800 shares $47,532.00 +58.1%0.7%0.2 $1.17 6/30/202325,800 shares $32,766.00 -39.3%0.5%0.1 $1.27 6/15/202342,500 shares $60,350.00 +6.5%0.7%0.2 $1.42 5/31/202339,900 shares $61,047.00 -48.8%0.8%0.2 $1.53 5/15/202377,900 shares $169,822.00 +144.2%1.5%0.3 $2.18 4/30/202331,900 shares $67,628.00 -3.3%0.8%0.1 $2.12 4/15/202333,000 shares $97,350.00 -29.9%0.8%1.1 $2.95 3/31/202347,100 shares $109,272.00 +262.3%1.1%1.8 $2.32 3/15/202313,000 shares $16,380.00 -21.2%0.3%0.8 $1.26 2/28/202316,500 shares $29,040.00 +17.9%0.4%1 $1.76 2/15/202314,000 shares $24,360.00 -21.4%0.3%0.9 $1.74 1/31/202317,800 shares $35,422.00 -41.3%0.3%1.1 $1.99 1/15/202330,300 shares $52,419.00 +31.7%0.7%1.9 $1.73 12/30/202223,000 shares $26,450.00 +33.7%0.5%1.6 $1.15 12/15/202217,200 shares $24,768.00 -12.2%0.4%1.9 $1.44 11/30/202219,600 shares $31,322.76 +22.5%0.4%1.2 $1.60 11/15/202216,000 shares $26,400.00 -20.8%0.4%0.8 $1.65 10/31/202220,200 shares $37,370.00 +3.1%0.4%0.8 $1.85 10/15/202219,600 shares $31,164.00 -9.7%0.4%0.7 $1.59 9/30/202221,700 shares $37,758.00 -10.0%0.5%0.8 $1.74 9/15/202224,100 shares $56,876.00 +28.2%0.5%0.8 $2.36 8/31/202218,800 shares $40,608.00 -68.4%0.4%0.7 $2.16“Crash Insurance” For Your Retirement (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. TPST Short Interest - Frequently Asked Questions What is Tempest Therapeutics' current short interest? Short interest is the volume of Tempest Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 1,130,000 shares of TPST short. 6.74% of Tempest Therapeutics' shares are currently sold short. Learn More on Tempest Therapeutics' current short interest. What is a good short interest ratio for Tempest Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TPST shares currently have a short interest ratio of 1.0. Learn More on Tempest Therapeutics's short interest ratio. What is a good short interest percentage for Tempest Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.74% of Tempest Therapeutics' floating shares are currently sold short. Is Tempest Therapeutics' short interest increasing or decreasing? Tempest Therapeutics saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,130,000 shares, an increase of 16.5% from the previous total of 969,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tempest Therapeutics' float size? Tempest Therapeutics currently has issued a total of 22,220,000 shares. Some of Tempest Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tempest Therapeutics currently has a public float of 16,760,000 shares. How does Tempest Therapeutics' short interest compare to its competitors? 6.74% of Tempest Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Tempest Therapeutics: Aileron Therapeutics, Inc. (0.31%), Marinus Pharmaceuticals, Inc. (8.23%), Connect Biopharma Holdings Limited (0.16%), Spero Therapeutics, Inc. (0.95%), Corvus Pharmaceuticals, Inc. (3.71%), BeyondSpring Inc. (10.07%), LifeVantage Co. (0.66%), Leap Therapeutics, Inc. (6.19%), Barinthus Biotherapeutics plc (0.04%), Anebulo Pharmaceuticals, Inc. (0.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Tempest Therapeutics stock? Short selling TPST is an investing strategy that aims to generate trading profit from Tempest Therapeutics as its price is falling. TPST shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tempest Therapeutics? A short squeeze for Tempest Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TPST, which in turn drives the price of the stock up even further. How often is Tempest Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TPST, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Aileron Therapeutics Short Interest Marinus Pharmaceuticals Short Interest Connect Biopharma Short Interest Spero Therapeutics Short Interest Corvus Pharmaceuticals Short Interest BeyondSpring Short Interest LifeVantage Short Interest Leap Therapeutics Short Interest Barinthus Biotherapeutics Short Interest Anebulo Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TPST) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarnings